Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies say, and pictured, Bridgette Melo, in Durham, North Carolina September 28, 2021. Mandatory Credit: Shawn Rocco/Duke University/Reuters